Citigroup out with positive commentary on $DXCM highlighting strong sales trends for Type 1 and 2 diabetes. Looking for a breakout through $405 as key resistance that can carry the stock to $430 in short term. Following up on $TWNK after a brief discussion in chat yesterday. Added color for product innovation, sales trends and expectations into holidays while technically stock is running strong on heavy volume. Reiterating bull case for $MANH second time since July after clean breakout this week through $100 resistance. Cloud business continues to remain strong.